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Abstract Reconstituted influenza virus envelopes (virosomes) 
containing the viral hemagglutinin (HA) represent an efficient 
fusogenic ellular delivery system. By interaction of HA with its 
natural receptors, sialylated lipids (gangliosides) or proteins, 
virosomes bind to cells and, following endocytic uptake, deliver 
their contents to the cytosol through fusion from within acidic 
endosomes. Here, we show that binding to sialic acid is not 
necessary for fusion. In the presence of streptavidin, virosomes 
containing a biotinylated lipid fused with liposomes lacking sialic 
acid if these liposomes also had a biotinylated lipid in their 
membranes. Moreover, fusion characteristics corresponded well 
with fusion of virosomes with ganglioside-containing liposomes. 
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1. Introduction 
dependent on the sialic-acid-binding characteristics of the 
HA molecules. 
In this study we investigated whether fusion of virosomes 
with target membranes lacking sialic acid residues is possible 
with an alternative mode of virosome-target membrane bind- 
ing. The latter was provided by the high-affinity interaction 
between streptavidin and biotin. As model target membranes 
we used liposomes with HA-binding gangliosides or without 
gangliosides but containing biotin-phosphatidylethanolamine 
(biotinPE). Virosomes, labeled with pyrene-phosphatidylchol- 
ine (pyrPC), were induced to fuse with these liposomes. Fu- 
sion was monitored by the decrease of pyrene excimer fluor- 
escence [8]. In this system, in the absence of target 
gangliosides, virosomes containing biotinPE fused specifically 
at acid pH with biotinPE-containing liposomes. This de- 
pended on binding at neutral pH in the presence of strepta- 
vidin. These results show that fusion of virosomes can be 
directed towards specific target membranes, which provides 
support for the further development of virosomes as an effi- 
cient and selective cellular delivery system. 
The plasma membrane receptor for the influenza virus en- 
velope glycoprotein hemagglutinin (HA) is formed by sialy- 
lated lipids (gangliosides) or proteins [1]. Receptor binding of 
HA mediates cellular uptake of the virus through receptor- 
mediated endocytosis, directing the virus to acidic endosomes. 
At the mildly acidic pH within endosomes, HA mediates 
merging of the viral with the endosomal membrane [24], 
resulting in the release of the viral genome into the cell cyto- 
sol. 
One of the key issues in biological and pharmacological 
research is how to bring about efficient and selective cytoplas- 
mic delivery of normally impermeant substances. We have 
previously shown that reconstituted influenza virus envelopes 
(virosomes) can be used to deliver proteins to the cytosol of 
target cells [5-7]. Although virosome-mediated delivery was 
efficient, because of the ubiquitous nature of target sialic 
acid residues it is not expected that macromolecules may be 
introduced into the cytosol of a selected set of target cells. 
Clearly, no specificity is possible if cytoplasmic delivery is 
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2. Materials and methods 
2.1. Materials 
Octaetheleneglycol m nododecyl ether (CleEs) and the hydrophob- 
ic resin Bio-Beads SM-2 (bead size 30e~1180, 180 ~tm) were obtained 
from Fluka Chemie AG (Buchs, Switzerland) and Bio-Rad (Hercules, 
CA, USA), respectiveiy. Prior to use Bio-Beads were conditioned with 
methanol and washed with 5.0 mM HEPES (pH 7.4) containing 0.15 
M NaC1 (HBS). PyrPC (1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-gly- 
cero-3-phosphocholine) was from Molecular Probes (Eugene, OR, 
USA). DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), DOPE 
(1,2-dioleoyl-sn-glycero-3 -phosphoethanolamine) and cholesterol 
were from Avanti Polar Lipids, Inc. (Alabaster, AL, US ). BiotinPE, 
the triethylammonium salt of N-(6-((biotinoyl)amino)hexanoyl)dipal- 
mitoyl-L-a-phosphatidylethanolamine, nd D-biotin were purchased 
from Pierce (Rockford, IL, USA). Gangliosides (type III, purified 
from bovine brain), and streptavidin were obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). Bovine serum albumin (BSA), 
fraction V, was from Life Technologies Ltd. (Paisley, UK). All other 
chemicals were of the highest grade available. 
2.2. Virus, virosomes and liposomes 
The X47 recombinant strain of influenza virus, carrying the HA of 
influenza AfVictoria/3/75, was grown and purified as described else- 
where [8]. Virosomes were prepared nd purified by sucrose density 
centrifugation asdescribed previously [5,9]. To incorporate biotinPE 
or pyrPC in the virosome membrane, C12Es-solubilized virus was 
added to either pyrPC or a mixture of pyrPC and biotinPE, after 
removal of the viral nucleocapsid by ultracentrifugation. The amounts 
of pyrPC and biotinPE, relative to the total amount of phospholipid, 
w re 14 and 3.0%, respectively. 
Liposomes were prepared from dry films of2.5 gmol total lipid, by 
rehydration with 0.5 ml HBS, 10 cycles of freezing and thawing, and 
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subsequent extrusion [10] through a Nucleopore polycarbonate mem- 
brane with a pore size of 0.2 gm (Costar Co., Cambridge, MA, USA), 
using a mini-extruder (Avanti Polar Lipids, Inc.). The liposomes were 
composed of DOPC, DOPE, cholesterol, biotinPE and ganglioside in 
the following molar ratios: 40:20:40:0:0, 40:15:40:5:0 and 
40:20:35:0:5. The phospholipid contents of virosomes and liposomes 
were determined by phosphate analysis [11] after digestion of the 
lipids [12]. 
2.3. Fluorescence measurement of membrane fusion 
Membrane fusion measurements were carried out with an SPF- 
500C spectrofluorometer (SLM Instruments Inc., Urbana, IL, USA) 
equipped with a thermostated cuvette holder and a magnetic stirring 
device. Virosomes (at a final concentration of 1.0 gM phospholipid) 
and streptavidin were added to a quartz microcuvette containing 
HBS/BSA (HBS supplemented with 1 mg/ml BSA). After 30 s lipo- 
somes were added. After an additional 2 min incubation period the 
medium was acidified to pH 5.1 by the addition of 25 gl of 0.10 M 
acetic acid, 0.10 M 2-[N-morpholino]ethanesulfonic acid (pH 4.1). The 
final volume was 0.7 ml. Fusion was continuously monitored at 37°C 
by the decrease of pyrene excimer fluorescence, at excitation and 
emission wavelengths of 345 nm (bandpass 0.5 nm) and 490 nm 
(bandpass 20 nm), respectively. A 475 nm cut-off filter was placed 
in the emission beam. Background fluorescence was assessed at infi- 
nite dilution of pyrPC, which was obtained by adding 35 gl of 0.20 M 
CluEs. Relative fluorescence was obtained by calculating 
100 ×(E0-E=)/(E0-E~), where E represents he excimer fluorescence 
intensity during fusion, and E0 and E= represent, respectively, the 
intensities at 490 nm at time zero and after the addition of C12Es, 
both corrected for dilution effects. After acidification of virosomes 
alone the pyrene excimer fluorescence declined slowly, at a rate of 
approximately 0.01%Is. All fusion curves were corrected for this value. 
3. Results and discussion 
3.1. Fusion of influenza virosomes with liposomes: effect of 
pre-fusion binding 
Fig. 1 (curve a) shows that virosomes fuse slowly with 
DOPC/DOPE/cholesterol iposomes without gangliosides. 
This slow fusion can be accounted for by hydrophobic mem- 
brane association of the HA fusion peptides [13,14] that are 
exposed upon acidification [15]. The possibility of specifically 
targeting influenza virosomes was investigated by co-reconsti- 
tuting biotinPE in the virosomes and measuring fusion of 
these virosomes with liposomes lacking gangliosides but con- 
taining biotinPE, in the presence of streptavidin (Fig. 1, curve 
b). After a 2 min incubation period at pH 7.4, acidification of 
the medium resulted in rapid fusion, with an initial rate of 
fluorescence change which was 40 times higher than the rate 
obtained in the absence of biotinPE in the target liposomes. In 
fact, fusion of biotinPE-containing virosomes with biotinPE- 
containing liposomes in the presence of streptavidin resembled 
fusion of the same virosomes with ganglioside-bearing lipo- 
somes (Fig. 1, curves b and c, respectively). At neutral pH (in 
the presence of streptavidin) no change of fluorescence above 
background was noted. In the absence of streptavidin (at pH 
5.1) fusion with biotinPE-containing liposomes was similar to 
fusion obtained in the absence of gangliosides or biotinPE in 
the target liposomes (see Fig. 1, curve a). 
The rates of fusion of these and control experiments are 
summarized in Fig. 2. Virosomes lacking biotinPE fused to 
a very limited extent with liposomes lacking gangliosides. The 
presence of streptavidin had no effect on the rates of fusion of 
these virosomes with any of the target liposomes, including 
ganglioside-containing liposomes. In the absence of strepta- 
vidin the rates of fusion of biotinPE-containing virosomes 
with any of the liposomes were essentially the same as those 
of unmodified virosomes. Thus, the presence of biotinPE in 
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Fig. 1. Fusion of influenza virosomes with liposomes. Liposomes 
(20 gM lipid) were added to pyrPC-labeled virosomes containing 
biotinPE (1.0 gM phospholipid), and the medium was acidified to 
pH 5.1. Pyrene excimer fluorescence was continuously monitored at 
37°C. The decrease of fluorescence was expressed relative to the dif- 
ference between the initial fluorescence and the fluorescence at infin- 
ite pyrPC dilution. The latter value represents complete (100%) fu- 
sion. Curves a, b and c were obtained with liposomes without 
gangliosides or biotinPE, liposomes with biotinPE and liposomes 
with gangliosides, respectively. In all cases 15 nM streptavidin was 
present. 
the virosomal membrane by itself did not affect the rate of 
membrane fusion. The only fusion reaction which was affected 
by the presence of streptavidin was that of biotinPE-contain- 
ing virosomes with biotinPE-containing liposomes, demon- 
strating that biotinPE-containing virosomes can be specifically 
targeted to biotinPE-containing membranes in the presence of 
streptavidin. Importantly, the rate of virosome fusion with 
biotinPE-containing liposomes in the presence of streptavidin 
(2.3 + 0.4% (mean+ S.D.) fluorescence/s) was very similar to 
that of ganglioside-containing liposomes (3.3 + 0.4% fluores- 
cence/s). Thus, the rapid fusion of influenza virus and viro- 
somes with membranes carrying sialic-acid-containing recep- 
tors can be mimicked by using streptavidin/biotin-mediated 
targeting to membranes without a binding moiety for the 
virosomal HA. 
3.2. Kinetics and specificity of streptavidin/biotin-mediated 
fusion 
The rates of fusion were determined over a range of lipo- 
some concentrations (Fig. 3). The kinetics of fusion after 
streptavidin/biotin-mediated targeting were almost identical 
to the kinetics of fusion after ganglioside-mediated pre-fusion 
binding. Fusion of virosomes with liposomes without ganglio- 
sides or biotinPE was about one order of magnitude slower 
over the whole range of liposome concentrations. 
Virosome targeting to liposomes with streptavidin/biotin 
depended on the streptavidin concentration, with an optimum 
in the rate of fusion at 10-15 nM streptavidin under the ex- 
perimental conditions employed (Fig. 4). Virosomes were used 
at a concentration of 30 nM biotin. Assuming that biotinPE is 
equally distributed over the inner and outer membrane leaf- 
P. Schoen et al./FEBS Letters 390 (1996) 315 318 
Tble to strepta- 
vidin. Since streptavidin has four biotin-binding sites, the op- 
timum rate of fnsion corresponded to an equimolar atio of 
streptavidin to virosomal biotin. 
A further demonstration of specificity came from the ob- 
servation that streptavidin-induced fusion of biotinPE-con- 
taining virosomes and liposomes was reduced to background 
levels in the presence of excess fluid-phase biotin (data not 
shown). Thus, streptavidin/biotin-mediated targeting of viro- 
somes to liposomes pecifically depended on simultaneous in- 
teraction of streptavidin with virosomal and liposomal biotin. 
The virosome and liposome membranes which fuse in this 
study are separated by the diameter of the streptavidin mole- 
cule, which is about 4.5 nm [16]. The interesting relationship 
between this distance and the extent of fusion may be inves- 
tigated further by the use of lipophilic biotin ligands with 
spacers of different lengths. 
3.3. Streptavidin/biotin-mediated HA- ependent fusion." 
Implications for the fusion mechanism and the 
development offusogenic delivery systems 
In this study we have demonstrated the feasibility of strep- 
tavidin/biotin-mediated targeting to permit HA-dependent fu- 
sion of virosomes with liposomes containing no binding moi- 
ety other than biotinPE. These observations have implications 
for the mechanism of HA-mediated fusion. Sialic-acid-con- 
taining receptors, such as gangliosides, have been shown to 
enhance the rate [14,17] and extent [17] of influenza virus 
fusion in liposomal model systems, by increasing prefusion 
binding of the virus to the target membrane at neutral pH. 
In the absence of gangliosides, fusion is also observed, but the 
rates and extents are relatively low [14,17] (see also Fig. 1). In 
addition to enhancing the extent of prefusion binding, it has 
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Fig. 2. Initial rates of fusion of virosomes with liposomes. Fusion 
was measured as in Fig. 1. Fusion rates were determined from the 
slopes of the tangents to the initial parts of the curves. Plain and 
biotinPE-containing virosomes (B-PE) were tested. Liposome prep- 
arations were without gangliosides or biotinPE (open bars), with 
biotinPE (solid bars) or with gangliosides (hatched bars). The abbre- 
viation +S indicates the use of streptavidin (15 nM). 
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Fig. 3. Effect of liposome concentration on the initial rates of fu- 
sion. The data were obtained as in Fig. 2 with liposomes lacking 
gangliosides or biotinPE (O), and with liposomes containing bio- 
tinPE (O) or gangliosides (zx). 
facilitates correct insertion of the HA fusion peptides into the 
target membrane [14,18]. This may result in higher rates of 
membrane fusion and, at temperatures below 37°C, in a de- 
tectable reduction of lag times preceding the actual onset of 
fusion [14]. 
A greater importance of the role of target sialic acid resi- 
dues in fusion has been postulated by others. In a study of 
fusion between influenza virus and planar lipid bilayers it was 
proposed that binding of HA to a sialic-acid-containing re- 
ceptor may fundamentally alter the course of the conforma- 
tional change in HA, to direct the fusion peptides to the target 
membrane [19]. In the present study streptavidin/biotin- 
mediated targeting resulted in fusion kinetics very similar to 
those observed with virosomes and liposomes containing 
gangliosides (Fig. 3). Thus, the notion that the interaction 
between HA and a sialic-acid-containing receptor has a fun- 
damental effect on the fusion process does not seem tenable. 
Rather, our present findings support previous conclusions of 
Stegmann et al. [14,17] that gangliosides do not influence the 
low-pH-dependent conformational change of HA or the char- 
acteristics of the membrane merger itself. 
It is well established that influenza virus fuses avidly with 
erythrocyte ghosts. Pre-treatment of the ghosts with neurami- 
nidase almost completely inhibits this fusion reaction [20]. 
Likewise, in our hands virosomes failed to show any decrease 
of excimer fluorescence upon incubation with neuraminidase- 
treated erythrocyte ghosts at acidic pH and 37°C (P. Schoen, 
unpublished results). Removal of sialic-acid-containing recep- 
tors from human T lymphocytic leukemia cells by neuramini- 
dase treatment [18], or from L929 cells (P. Schoen, unpub- 
lished results), inhibits binding of influenza virus by 60-70%. 
Moreover, in the case of L929 cells, the virosome particles 
which did bind (at 4°C) showed essentially no change of pyr- 
ene excimer fluorescence during a subsequent 1 h incubation 
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Fig. 4. Initial rates of fusion of biotinPE-containing virosomes with 
biotinPE-containing liposomes (20 PM) as function of streptavidin 
concentration. 
allowing functional receptor-mediated endocytosis and subse- 
quent acidic-pH-mediated fusion from within the endosomes. 
Thus, the delivery of virosomal contents can in principle be 
specifically targeted, when the normal HA-dependent binding 
to target cells can be inhibited [21,22]. Here we used the high- 
affinity streptavidinlbiotin system as targeting device, but 
there is no reason why other modes of targeting should not 
be applicable as well. This has promising implications for 
development of virosomes as efficient and selective delivery 
systems. 
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